Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ispinesib in Taxane-Resistant Metastatic Prostate Cancer
NCT00096499Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 2005
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ispinesib in prostate cancer (PCa), sponsored by National Cancer Institute. Started Apr 2005; status: completed.
02
Drugs
ispinesib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00096499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00096499.